Patents by Inventor Jonathan S. Cebon

Jonathan S. Cebon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8420791
    Abstract: The present invention relates to the treatment, diagnosis, and prophylaxis of cancer based on the expression of foxp3.
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: April 16, 2013
    Assignee: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lisa Michelle Ebert, Weisan Chen, Jonathan S. Cebon, Ian Davis
  • Publication number: 20130011496
    Abstract: A cancer testis antigen biomarker useful to determine whether a non- small cell lung cancer tumor is likely to respond to neoadjuvant chemotherapy is provided. Methods of using the biomarker in the diagnosis, treatment and prognosis of non-small cell lung cancer also are provided.
    Type: Application
    Filed: November 23, 2010
    Publication date: January 10, 2013
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Jonathan S. Cebon, Arun Azad, Sid Deb
  • Publication number: 20100143359
    Abstract: The present invention relates to the treatment, diagnosis, and prophylaxis of cancer based on the expression of foxp3.
    Type: Application
    Filed: November 27, 2007
    Publication date: June 10, 2010
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lisa Michelle Ebert, Weisan Chen, Jonathan S. Cebon, Ian Davis
  • Publication number: 20100068142
    Abstract: The invention relates to the identification of melanoma repopulating cells, characterization of these cells, and diagnostic and therapeutic methods based on an understanding of the properties of these cells.
    Type: Application
    Filed: October 3, 2007
    Publication date: March 18, 2010
    Inventors: Craig Gedye, Ian Davis, Jonathan S. Cebon